Summary
The MAO-A and MAO-B activities in the striatum and the rest of the forebrain of young adult and aged rats were determined and compared. There was no significant difference in Km values of MAO-A for 5-HT or of-B for benzylamine in any of the brain regions of both rat groups. With increase in age, the Vmax value of MAO-A in the forebrain decreased; in the striatum the Vmax values of MAO-A and -B increased with age. The MAO-A concentrations, measured by enzyme titration with clorgyline or 1-deprenyl as the titre, were the same in both brain regions of young and aged rats, but in both brain regions of aged rats, MAO-B concentrations were greater than those in young rats. The MAO-B concentrations increased in parallel with the increases in Vmax indicating that the increase with age was due to increase in the number of MAO molecules.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arai Y, Stenstrom A, Oreland L (1985) The effect of age on intra- and extraneuronal monoamine oxidase-A and-B activities in the rat brain, Biogenic Amines 2: 65–71
Dupont H, Davies DS, Strolin Benedetti M (1987) Inhibition of cytochrome P-450-dependent oxidation reactions by MAO inhibitors in rat liver microsomes. Biochem Pharmacol 36: 1651–1657
Egashira T, Ekstedt B, Kinemuchi H, Wiberg A, Oreland L (1976) Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat. Med Biol 54: 272–277
Fowler CJ, Oreland L, Wiberg A, Carlsson A, Magnusson, T (1979) The inhibition of rat monoamine oxidase-B by J-508 [N-methyl-N-propargyl-(l-indanyl)-ammonium hydrochloride], and its use for the titration of this enzyme form. Med Biol 57: 406–411
Fowler CJ, Wiberg A, Oreland L, Marcusson J, Winblad B (1980a) The effect of age on the activity and molecular properties of human monoamine oxidase. J Neural Transm 49: 1–20
Fowler CJ (1980b) Potentiation of the inhibition of rat liver monoamine oxidase-A by clorgyline after pretreatment with SKF 525 A. Med Biol 58: 285–287
Fowler CJ, Oreland L, Marcusson J, Winblad B (1980c) Titration of human brain monoamine oxidase-A and -B by clorgylie and L-deprenyl. Naunyn Schmiedebergs Arch Pharmacol 311: 263–272
Fowler CJ, Oreland L, Callingham BA (1981) The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications. J Pharm Pharmacol 33: 341–347
Gomez N, Unzeta M, Tipton KF, Anderson MC, O'Carroll A-M (1986) Determination of monoamine oxidase concentrations in rat liver by inhibitor binding. Biochem Pharmacol 35: 4467–4472
Horita A (1978) Neuropharmacology and aging. In: Roberts J, Adelman RC, Cristofalo VJ (eds) Pharmacological intervention in the aging process. Plenum Press, New York, pp 171–185
Johnston JP (1968) Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 17: 1285–1297
Kinemuchi H, Fowler CJ, Tipton KF (1984) The substrate specificities of the two forms of monoamine oxidase. In: Tipton KF, Dostert P, Strolin Benedetti M (eds) Monoamine oxidase and disease. Academic Press, London, pp 53–62
Kinemuchi H, Arai Y, Toyoshima Y (1985) Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity. Neurosci Lett 58: 195–200
Knoll J, Magyar K (1972) Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv Biochem Psychopharmacol 5: 393–408
Langston JW, Irwin I, DeLanney LE (1987) Molecular mechanism of MPTP-induced toxicity VII. The biotransformation of MPTP and disposition of MPP+: the effects of aging. Life Sci 40: 749–754
Leung TKC, Lai JCK, Lim L (1981) The regional distribution of monomine oxidase activities towards different substrates: effects in rat brain of chronic administration of manganese chloride and of ageing. J Neurochem 36: 2037–2043
Mantle TJ, Garrett NJ, Tipton KF (1976) The development of monoamine oxidase in rat liver and brain. FEBS Lett 64: 227–230
Markwell MAK, Haas SM, Bieber LL, Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Analyt Biochem 87: 206–210
Oreland L, Fowler CJ, Carlsson A, Magnusson T (1980) Monoamine oxidase-A and -B activity in the rat brain after hemitransection. Life Sci 26: 139–146
Oreland L, Arai Y, Stenstrom A (1984) Age, neuro-psychiatric diseases and brain monoamine oxidase. In: Tipton KF, Dostert P, Strolin Benedetti M (eds) Monoamine oxidase and disease. Academic Press, London
Robinson DS, Davis JM, Nies A, Colburn RW, Davis JN (1972) Bourne HR, Bunney WE, Shaw DM, Coppen AJ (1972) Ageing, monoamines, and monoamine-oxidase levels. Lancet 1: 290–291
Stenstrom A, Arai Y, Oreland L (1985) Intra- and extraneuronal monoamine oxidase-A and -B activities after central axotomy (hemisection) on rats. J Neural Transm 61: 105–113
Strolin Benedetti M, Keane PE (1980) Differential changes in monoamine oxidase A and B actitity in the aging rat brain, J Neurochem 35: 1026–1032
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arai, Y., Kinemuchi, H. Differences between monoamine oxidase concentrations in striatum and forebrain of aged and young rats. J. Neural Transmission 72, 99–105 (1988). https://doi.org/10.1007/BF01250233
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01250233